Home > Boards > US Listed > Biotechs > iBio, Inc. (IBIO)

Oh boy...better off going to casino, not hoping

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
croptop Member Profile
 
Followed By 16
Posts 3,281
Boards Moderated 0
Alias Born 03/13/13
160x600 placeholder
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 10/13/2021 4:07:16 PM
Annual Report (10-k) Edgar (US Regulatory) - 9/28/2021 4:13:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/27/2021 5:31:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 7:46:16 AM
iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 9/27/2021 7:30:00 AM
iBio to Participate in the Cantor 2021 Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/20/2021 4:30:00 PM
iBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Monday, September 27, 2021 GlobeNewswire Inc. - 9/20/2021 7:30:00 AM
iBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/7/2021 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/31/2021 4:31:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/26/2021 7:11:29 AM
iBio Appoints William D. Clark to its Board of Directors GlobeNewswire Inc. - 8/26/2021 7:00:00 AM
iBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics GlobeNewswire Inc. - 8/25/2021 7:30:00 AM
iBio says successful in preclinical studies for subunit COVID-19 vaccine candidate Seeking Alpha - 7/16/2021 7:24:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/16/2021 6:04:34 AM
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate GlobeNewswire Inc. - 7/15/2021 5:10:00 PM
iBio establishes oncology drug discovery pipeline with three new antibody programs Seeking Alpha - 7/8/2021 4:23:04 PM
iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs GlobeNewswire Inc. - 7/8/2021 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2021 5:20:28 PM
iBio adds veteran biopharmaceutical executive to board of directors Seeking Alpha - 6/9/2021 4:44:08 PM
iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink GlobeNewswire Inc. - 6/9/2021 4:30:00 PM
iBio to Present at the UBS Global Healthcare Virtual Conference GlobeNewswire Inc. - 5/19/2021 4:30:00 PM
iBio Q1 net loss widens as expenses soar year-over-year; shares fall 6% Seeking Alpha - 5/17/2021 10:08:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2021 7:16:10 AM
iBio revenue in-line Seeking Alpha - 5/17/2021 7:04:02 AM
iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/17/2021 7:00:00 AM
croptop   Wednesday, 11/05/14 12:23:33 PM
Re: john _a_1990_420 post# 10691
Post # of 26342 
Oh boy...better off going to casino, not hoping a PR about someone boosts a share price...Not a way to preserve capital..

If anyone believes this post contains anything false, tortious or libelous, please point it out. I will promptly retract it and apologize or else explain why I believe you are wrong.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences